Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-22 @ 2:07 PM
Study NCT ID:
NCT02950259
Status:
COMPLETED
Last Update Posted:
2025-12-03
First Post:
2016-10-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Sponsor:
Providence Health & Services
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
16-126B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |